公司資料
Precigen 股價、新聞與催化劑
- 股票代碼:
- PGEN
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
7.17 USD (-0.42%)
收盤價
最後更新: 2026年8月24日
1.38B USD
市值
股價為何變動
As of Aug 24, 2026, PGEN closed down 0.42% at $7.17. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Precigen is a biotechnology company focused on gene and cell therapies, as well as engineered biologics. Its platform aims to create novel treatments across several disease areas.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Precigen sits in advanced biotechnology.
商業模式特徵
The company depends on platform validation, clinical data, and the ability to convert engineered biology into value.
生技產業定位
Precigen is a platform biotech name whose stock reacts to progress in cell and gene therapy programs.
未來催化劑
- Precigen’s catalysts are PRGN-2012 and its UltraCAR-T platform, especially any update in recurrent respiratory papillomatosis or other immuno-oncology programs. The company needs to keep proving the platform can produce tangible clinical value.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。